BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
21 mai 2021 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, May 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
04 mai 2021 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) -- The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians...
BioSig Technologies, Inc. Invited to Present at Wall Street Conference
03 mai 2021 12h00 HE
|
BioSig Technologies, Inc.
Westport, CT, May 03, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
27 avr. 2021 09h30 HE
|
BioSig Technologies, Inc.
Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) -- The clinic is conducting an evaluation of the PURE EP(tm) System, a signal processing technology for cardiac arrhythmia treatmentsNew installation...
BioSig Expands Commercial Team in Two Strategic Regions
15 avr. 2021 11h45 HE
|
BioSig Technologies, Inc.
Westport, CT, April 15, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform
14 avr. 2021 09h29 HE
|
BioSig Technologies, Inc.
Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) -- The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular...
BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study
13 avr. 2021 09h32 HE
|
BioSig Technologies, Inc.
Westport, CT, April 13, 2021 (GLOBE NEWSWIRE) -- 51 patients undergoing elective cardiac ablation treatments were enrolled in the trial at Mayo Clinic, Massachusetts General Hospital, and St....
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)
09 avr. 2021 09h32 HE
|
BioSig Technologies, Inc.
Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- Global leaders, including Amazon, Bayer, and GE Healthcare, joined the AAIH to date to collaborate on developing novel solutions to improve the...
EP Lab Digest Features Physician Experience with BioSig’s Cardiac Signal Acquisition Technology
08 avr. 2021 09h32 HE
|
BioSig Technologies, Inc.
Westport, CT, April 08, 2021 (GLOBE NEWSWIRE) -- Leading industry publication highlights the rising importance of intracardiac signals in complex cardiac ablations that treat irregular heart rhythm...
BioSig lands Commercial Sales to Leading Hospital System
06 avr. 2021 09h45 HE
|
BioSig Technologies, Inc.
Westport, CT, April 06, 2021 (GLOBE NEWSWIRE) -- World class healthcare institution adopts PURE EP™ across multiple StatesMedical centers resuming elective procedures helps drive sales acceleration...